(NYSE: INSP) Inspire Medical Systems's forecast annual revenue growth rate of 10.87% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.31%.
Inspire Medical Systems's revenue in 2025 is $882,622,000.On average, 22 Wall Street analysts forecast INSP's revenue for 2025 to be $26,786,835,940, with the lowest INSP revenue forecast at $25,627,774,788, and the highest INSP revenue forecast at $27,675,091,128. On average, 22 Wall Street analysts forecast INSP's revenue for 2026 to be $30,654,537,870, with the lowest INSP revenue forecast at $28,446,539,450, and the highest INSP revenue forecast at $32,630,375,382.
In 2027, INSP is forecast to generate $35,071,115,838 in revenue, with the lowest revenue forecast at $31,468,118,022 and the highest revenue forecast at $38,499,775,050.